Abstract
BACKGROUND—Methicillin resistant Staphylococcus aureus (MRSA) infection is increasingly found in patients with cystic fibrosis (CF). AIMS—To determine whether MRSA infection has a deleterious effect on the clinical status of children with CF. METHODS—Children with MRSA in respiratory cultures during a seven year period were identified and compared with controls matched for age, sex, and respiratory function. Respiratory function tests, anthropometric data, Shwachman-Kulczycki score, Northern chest x ray score, intravenous and nebulised antibiotic therapy, and steroid therapy were compared one year before and one year after MRSA infection. RESULTS—From a clinic population of 300, 10 children had positive sputum or cough swab cultures for MRSA. Prevalence rose from 0 in 1992-1994 to 7 in 1998. Eighteen controls were identified. Children with MRSA showed significant worsening of height standard deviation scores and required twice as many courses of intravenous antibiotics as controls after one year. They had significantly worse chest x ray scores at the time of the first MRSA isolate and one year later, but showed no increase in the rate of decline in chest x ray appearance. There was a trend towards lower FEV1 and FEF25-75 in children with MRSA. There were no significant differences between the two groups with respect to change in weight, body mass index, or Shwachman score. There was no significant difference in prior use of steroids or nebulised antibiotics. CONCLUSION—MRSA infection in children with CF does not significantly affect respiratory function, but may have an adverse effect on growth. Children with MRSA require significantly more courses of intravenous antibiotics and have a worse chest x ray appearance than controls.
Full Text
The Full Text of this article is available as a PDF (119.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Boxerbaum B., Jacobs M. R., Cechner R. L. Prevalence and significance of methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis. Pediatr Pulmonol. 1988;4(3):159–163. doi: 10.1002/ppul.1950040307. [DOI] [PubMed] [Google Scholar]
- Branger C., Fournier J. M., Loulergue J., Bouvet A., Goullet P., Boutonnier A., de Gialluly C., Couetdic G., Chomarat M., Jaffar-Banjee M. C. Epidemiology of Staphylococcus aureus in patients with cystic fibrosis. Epidemiol Infect. 1994 Jun;112(3):489–500. doi: 10.1017/s0950268800051190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cole T. J., Freeman J. V., Preece M. A. Body mass index reference curves for the UK, 1990. Arch Dis Child. 1995 Jul;73(1):25–29. doi: 10.1136/adc.73.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Conway S. P., Pond M. N., Bowler I., Smith D. L., Simmonds E. J., Joanes D. N., Hambleton G., Hiller E. J., Stableforth D. E., Weller P. The chest radiograph in cystic fibrosis: a new scoring system compared with the Chrispin-Norman and Brasfield scores. Thorax. 1994 Sep;49(9):860–862. doi: 10.1136/thx.49.9.860. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Freeman J. V., Cole T. J., Chinn S., Jones P. R., White E. M., Preece M. A. Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child. 1995 Jul;73(1):17–24. doi: 10.1136/adc.73.1.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Givney R., Vickery A., Holliday A., Pegler M., Benn R. Methicillin-resistant Staphylococcus aureus in a cystic fibrosis unit. J Hosp Infect. 1997 Jan;35(1):27–36. doi: 10.1016/s0195-6701(97)90165-1. [DOI] [PubMed] [Google Scholar]
- Mackenzie D., Edwards A. MRSA: the psychological effects. Nurs Stand. 1997 Dec 3;12(11):49–56. doi: 10.7748/ns.12.11.49.s57. [DOI] [PubMed] [Google Scholar]
- McAllister T. A., Mocan H., Murphy A. V., Beattie T. J. Antibiotic susceptibility of staphylococci from CAPD peritonitis in children. J Antimicrob Chemother. 1987 Jan;19(1):95–100. doi: 10.1093/jac/19.1.95. [DOI] [PubMed] [Google Scholar]
- Máiz L., Cantón R., Mir N., Baquero F., Escobar H. Aerosolized vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infection in cystic fibrosis. Pediatr Pulmonol. 1998 Oct;26(4):287–289. doi: 10.1002/(sici)1099-0496(199810)26:4<287::aid-ppul9>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
- SHWACHMAN H., KULCZYCKI L. L. Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. AMA J Dis Child. 1958 Jul;96(1):6–15. doi: 10.1001/archpedi.1958.02060060008002. [DOI] [PubMed] [Google Scholar]
- Storch G. A., Rajagopalan L. Methicillin-resistant Staphylococcus aureus bacteremia in children. Pediatr Infect Dis. 1986 Jan-Feb;5(1):59–67. doi: 10.1097/00006454-198601000-00012. [DOI] [PubMed] [Google Scholar]
- Thomas S. R., Gyi K. M., Gaya H., Hodson M. E. Methicillin-resistant Staphylococcus aureus: impact at a national cystic fibrosis centre. J Hosp Infect. 1998 Nov;40(3):203–209. doi: 10.1016/s0195-6701(98)90138-4. [DOI] [PubMed] [Google Scholar]